Clinical Trials Directory

Trials / Completed

CompletedNCT02061839

Prevention of Melasma Relapse During Summertime

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Centre de Pharmacologie Clinique Applique a la Dermatologie · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Main objective is to show that a photoprotective sunscreen having a protection against the visible light is more effective than a sunscreen having the same UVA AND UVB protection but with a low (weak) protection against the visible, to prevent the relapses of the melasma during the summertime.

Detailed description

40 melasma affected women will be included and randomized in two parallel groups (one group protected by a UVA+UVB+visible extended sunscreen and one group group protected by a UVA+UVB sunscreen). There will be 3 visits: Baseline, T2.5months and T5months (final visit). Products application frequency: twice daily(morning and afternoon) and additional applications every 2 hours in case of solar exposure. Main evaluation criterion: the MASI score assessed from standardized photographs (system VISIA, Canfield Scientific, USA) at Baseline, middle and end of study.

Conditions

Interventions

TypeNameDescription
OTHERSunscream with visible light protection
OTHERSunscream

Timeline

Start date
2013-03-01
Primary completion
2013-08-01
Completion
2013-10-01
First posted
2014-02-13
Last updated
2014-02-13

Source: ClinicalTrials.gov record NCT02061839. Inclusion in this directory is not an endorsement.

Prevention of Melasma Relapse During Summertime (NCT02061839) · Clinical Trials Directory